Literature DB >> 29947722

Whole genome sequence of Mycobacterium kansasii isolates of the genotype 1 from Brazilian patients with pulmonary disease demonstrates considerable heterogeneity.

Edson Machado1, Sidra Ezidio Gonçalves Vasconcellos2, Camillo Cerdeira1,3, Lia Lima Gomes2, Ricardo Junqueira3, Luciana Distasio de Carvalho4, Jesus Pais Ramos4, Paulo Redner4, Carlos Eduardo Dias Campos4, Paulo Cesar de Souza Caldas4, Ana Paula Chaves Sobral Gomes4, Telma Goldenberg4, Fatima Fandinho Montes4, Fernanda Carvalho de Queiroz Mello5, Vinicius de Oliveira Mussi6, Elena Lasunskaia6, Dick van Soolingen7, Antonio Basílio de Miranda3, Leen Rigouts8, Bouke C de Jong8, Conor J Meehan8, Marcos Catanho1, Philip N Suffys2,8.   

Abstract

Mycobacterium kansasii is an opportunistic pathogen and one of the most commonly encountered species in individuals with lung disease. We here report the complete genome sequence of 12 clinical isolates of M. kansasii from patients with pulmonary disease in Brazil.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29947722      PMCID: PMC6012682          DOI: 10.1590/0074-02760180085

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


Nontuberculous Mycobacterium (NTM) species are widespread in the (man-made) environment and some species cause opportunistic infections in humans. Mycobacterium kansasii, frequently isolated from tap water, is a slow-growing photochromogenic NTM and a pathogen that is commonly isolated from patients with pre-existing lung disease, similar to other NTM clinical species such as M. abscessus, M. avium complex, M. malmoense and M. xenopi. In the USA and South America M. kansasii is the second most isolated NTM after M. avium complex , while in Rio de Janeiro, it is the most frequent NTM to cause pulmonary disease. Besides chronic bronchopulmonary disease, M. kansasii causes other clinical manifestations such as lymphadenitis , skin and soft tissue infection , tenosynovitis, arthritis, osteomyelitis and disseminated infection in patients co-infected with human immunodeficiency virus. Seven major genotypes (I to VII) of M. kansasii have been described and while human isolates are mainly of types I and II (with type II mainly HIV-related) , , environmental isolates are mostly of the other subtypes. Type I has been described as a heterogeneous group, incompletely characterized on the genomic level. , Recently, the genome sequence of the ATCC strain 12478 Hauduroy isolated in Kansas in 1955 has been compared with that of the M. tuberculosis strain H37Rv , while other M. kansasii genomes are available from environmental , human and simian sources. Here, we report the genome sequence of 12 clinical M. kansasii isolates belonging to genotype I, as determined by hsp65 sequencing. The strains were isolated from human Brazilian patients with pulmonary disease and possibly earlier tuberculosis. Nine isolates were from sputum, two from bronchoalveolar lavage (7287 and 10742) and one of unknown origin (1580). Isolates were from residents of the state of Rio de Janeiro (n = 7), Pernambuco (n = 3), Rio Grande do Sul (n = 1), and Santa Catarina (n = 1). Genomic DNA libraries were constructed using the Nextera XT DNA library kit and whole-genome shotgun sequencing was performed on the Illumina HiSeq2500 platform, generating paired end reads of 2 × 100 bp. Genomes were de novo assembled using SPAdes software version 3.11.1 , and annotated with RAST (Table). No evidence for the presence of plasmids was observed.
TABLE

Genome features, predicted genes, and GenBank accession numbers of Mycobacterium kansasii strains isolated in Brazil from patients with pulmonary disease

IsolateAccessionLocationType (hsp65)ReadsGenome size (bp)ContigsCoverage (x)Genes
BR3657PQOL00000000RJ1Bd 18,094,4086,374,28229480.905,965t
BR6498ª PQOM00000000RS1A9,038,2246,225,83831737.375,804
BR7287PQON00000000RJ1A19,684,8906,282,32627479.595,842
BR6884PQOO00000000RJ1A21,305,2546,411,468280125.915,980
BR6849PQOP00000000SC1A16,399,3046,464,04726578.896,023
BR10953b PQOQ00000000RJ1A14,895,9386,284,87929752.025,850
BR10742b PQOR00000000RJ1A14,634,4906,289,61928253.585,864
BR1580PQOS00000000RJ1B20,820,3726,307,487226143.205,913
BR4404PQOT00000000RJ1B4,686,1346,282,92346631.435,880
BR8835ª PQOU00000000PE1B16,906,2366,228,38132153.455,775
BR8837c PQOV00000000PE1B13,311,4446,213,26824775.415,773
BR8839c PQOW00000000PE1B9,434,8926,178,86227052.485,727

a: resistant to rifampicin; b and c are pairs of isolates obtained from a single patient each. Isolates were from patients residents of Rio Grande do Sul (RS), Rio de Janeiro (RJ), Santa Catarina (SC) and Pernambuco (PE); d: 1B differs from the hsp65 sequence 1A of the ATCC 12478 strain by a SNP A to G at genome position 39635339 (GenBank KJ186611.1).

a: resistant to rifampicin; b and c are pairs of isolates obtained from a single patient each. Isolates were from patients residents of Rio Grande do Sul (RS), Rio de Janeiro (RJ), Santa Catarina (SC) and Pernambuco (PE); d: 1B differs from the hsp65 sequence 1A of the ATCC 12478 strain by a SNP A to G at genome position 39635339 (GenBank KJ186611.1). To evaluate the overall similarity of the genomes of the isolates from Brazil with that of the isolate ATCC 12478, we also compared the 12 genomes with the ATCC reference genome using the BLAST Ring Image Generator (BRIG) program (Fig. 1).
Fig. 1:

BLAST ring image of the 12 Brazilian genomes against the ATCC 12478 reference genome.

We observed many deletions spread in the genomes that were either shared by all or part of the isolates. Three isolates (1580, 3657 and 4404) presented a region of difference of about 27 kb causing the loss of five helicases, a restriction endonuclease and two hypothetical proteins. We also observed multiple deletions shared by the isolates 1580, 3657, 4404, 8835, 8837 and 8839 (Fig. 1). In addition, a reference-based single-nucleotide polymorphism (SNP) calling was performed against the genome of the M. kansasii ATCC 12478 strain using both Snippy (version 3.2; https://github.com/tseemann/snippy) and the wgSNP module of BioNumerics v7.6 (Applied Maths, Sint-Martens-Latem, Belgium). Most isolates presented homogeneously distributed SNPs over the entire genome, except for isolates 6849 and 6498 which clearly presented regions of higher SNP frequency (data not shown). As demonstrated by a Neighbour-Joining phylogenetic tree based on 5,607,341 sites and 1000 bootstrap replicates (Fig. 2), three groups were observed when compared to the genome of the ATCC strain, one presenting less than 100 SNP (n = 4) (middle part), a second with either less than 5,000 SNPs (n = 1) and more than 10,000 SNPs (n = 1) (lower part) and a third group with more than 10,000 SNPs (n = 6) (upper part). We observed an association between SNP-based grouping and phylogeny on basis of large deletions, that led us suggest that the third group has evolved from the common ancestor.
Fig. 2:

Neighbor-Joining SNP-based tree of the 12 Brazilian isolates and the ATCC 12478 reference genome.

From two patients, we performed whole genome sequencing of two isolates each; the pair of isolates from a patient from Rio de Janeiro (10742 and 10953) had 0 SNPs difference; the second pair from a patient from Recife (8837 and 8839) presented 277 mutations (data not shown). Additionally, two isolates (6498 and 8835) presented a Minimal Inhibitory Concentration of > 1 µg/mL for rifampicin in vitro and both presented a non-synonymous SNP, localized respectively at position 4267612 (C to G) and 4267613 (A to C), causing an amino acid change in codon 411 of rpoB of respectively Gln to Glu and of Gln to Pro. We as such confirm the scarce existing data on the association between resistance against rifampicin and presence of point mutations in M. kansasii rpoB gene. Indeed, point mutations in rpoB gene are the main reason for resistance against rifampicin and this has been confirmed in several bacteria. Also, molecular determinants of drug resistance in M. kansasii has been recently suggested by Bakuła et al. . Among the present isolates, we observed considerable differences of in vitro virulence in macrophages as measured by growth and induction of necrosis and of cytokine production (data not shown). In conclusion, these are preliminary data on the variability within the M. kansasii genotype 1 in Brazil and, even on the basis of this small sample number, we evidenced three genetic groups that are separated by the presence of large number of SNPs throughout the genome and by the pattern of large deletions. One grouping of strains from Rio de Janeiro is highly similar to the ATCC strain Hauduroy (< 100 SNPs) that was isolated more than 70 years ago in the US. A second group of human isolates from Rio de Janeiro and Pernambuco presented over 10,000 SNPs when compared to the ATCC strain. We also observed an association between genotypes and geographic origin of isolates, separating those from the states of Rio de Janeiro, Pernambuco and Santa Catarina. Our observation of considerable differences of in vitro and in vivo virulence and their differences on the genome level is under investigation.
  20 in total

Review 1.  Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature.

Authors:  Sang Hoon Han; Kyoung Min Kim; Bum Sik Chin; Suk Hoon Choi; Han Sung Lee; Myung Soo Kim; Su Jin Jeong; Hee Kyoung Choi; Chang Oh Kim; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  J Korean Med Sci       Date:  2010-01-19       Impact factor: 2.153

2.  Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey.

Authors:  Caroline Taillard; Gilbert Greub; Rainer Weber; Gaby E Pfyffer; Thomas Bodmer; Stefan Zimmerli; Reno Frei; Stefano Bassetti; Peter Rohner; Jean-Claude Piffaretti; Enos Bernasconi; Jacques Bille; Amalio Telenti; Guy Prod'hom
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii.

Authors:  Zofia Bakuła; Magdalena Modrzejewska; Lian Pennings; Małgorzata Proboszcz; Aleksandra Safianowska; Jacek Bielecki; Jakko van Ingen; Tomasz Jagielski
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

4.  BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons.

Authors:  Nabil-Fareed Alikhan; Nicola K Petty; Nouri L Ben Zakour; Scott A Beatson
Journal:  BMC Genomics       Date:  2011-08-08       Impact factor: 3.969

5.  Disseminated Mycobacterium kansasii infection with hepatic abscesses in a renal transplant recipient.

Authors:  P Kaur; J A Fishman; J Misdraji; M C Varma; C N Kotton
Journal:  Transpl Infect Dis       Date:  2011-04-05       Impact factor: 2.228

6.  The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.

Authors:  Wouter Hoefsloot; Jakko van Ingen; Claire Andrejak; Kristian Angeby; Rosine Bauriaud; Pascale Bemer; Natalie Beylis; Martin J Boeree; Juana Cacho; Violet Chihota; Erica Chimara; Gavin Churchyard; Raquel Cias; Rosa Daza; Charles L Daley; P N Richard Dekhuijzen; Diego Domingo; Francis Drobniewski; Jaime Esteban; Maryse Fauville-Dufaux; Dorte Bek Folkvardsen; Noel Gibbons; Enrique Gómez-Mampaso; Rosa Gonzalez; Harald Hoffmann; Po-Ren Hsueh; Alexander Indra; Tomasz Jagielski; Frances Jamieson; Mateja Jankovic; Eefje Jong; Joseph Keane; Wo-Jung Koh; Berit Lange; Sylvia Leao; Rita Macedo; Turid Mannsåker; Theodore K Marras; Jeannette Maugein; Heather J Milburn; Tamas Mlinkó; Nora Morcillo; Kozo Morimoto; Dimitrios Papaventsis; Elia Palenque; Mar Paez-Peña; Claudio Piersimoni; Monika Polanová; Nalin Rastogi; Elvira Richter; Maria Jesus Ruiz-Serrano; Anabela Silva; M Pedro da Silva; Hulya Simsek; Dick van Soolingen; Nora Szabó; Rachel Thomson; Teresa Tórtola Fernandez; Enrico Tortoli; Sarah E Totten; Greg Tyrrell; Tuula Vasankari; Miguel Villar; Renata Walkiewicz; Kevin L Winthrop; Dirk Wagner
Journal:  Eur Respir J       Date:  2013-04-18       Impact factor: 16.671

Review 7.  Pulmonary Disease Caused by Non-Tuberculous Mycobacteria.

Authors:  Nasstasja Wassilew; Harald Hoffmann; Claire Andrejak; Christoph Lange
Journal:  Respiration       Date:  2016-05-21       Impact factor: 3.580

8.  Insights on the emergence of Mycobacterium tuberculosis from the analysis of Mycobacterium kansasii.

Authors:  Joyce Wang; Fiona McIntosh; Nicolas Radomski; Ken Dewar; Roxane Simeone; Jost Enninga; Roland Brosch; Eduardo P Rocha; Frédéric J Veyrier; Marcel A Behr
Journal:  Genome Biol Evol       Date:  2015-02-25       Impact factor: 3.416

9.  Mycobacterium kansasii Pneumonia with Mediastinal Lymphadenitis in a Patient with Acute Myeloid Leukemia: Successful Treatment to Stem Cell Transplantation.

Authors:  Yeon Geun Choi; Sung Yeon Cho; Dong Gun Lee; Eunjung Yim; Hyonsoo Joo; Seongyul Ryu; Jae Ki Choi; Hee Je Kim
Journal:  Infect Chemother       Date:  2017-01-19

10.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

View more
  2 in total

1.  Comparative Genomic and Transcriptomic Analyses of Mycobacterium kansasii Subtypes Provide New Insights Into Their Pathogenicity and Taxonomy.

Authors:  Qingtian Guan; Roy Ummels; Fathia Ben-Rached; Yara Alzahid; Mohammad S Amini; Sabir A Adroub; Jakko van Ingen; Wilbert Bitter; Abdallah M Abdallah; Arnab Pain
Journal:  Front Cell Infect Microbiol       Date:  2020-03-24       Impact factor: 5.293

2.  Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China.

Authors:  Yinjuan Guo; Yanhua Cao; Haican Liu; Jinghui Yang; Weiping Wang; Bingjie Wang; Meilan Li; Fangyou Yu
Journal:  Microbiol Spectr       Date:  2022-01-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.